Imoigele P Aisiku1, Jose-Miguel Yamal, Pratik Doshi, Maria Laura Rubin, Julia S Benoit, Julia Hannay, Barbara C Tilley, Shankar Gopinath, Claudia S Robertson. 1. From the Department of Emergency Medicine (I.P.A.), Brigham and Women's Hospital, Boston, Massachusetts; and Division of Biostatistics (J.M.-Y., M.L.R., B.C.T.), University of Texas School of Public Health; Department of Emergency Medicine and Internal Medicine (P.D.), University of Texas Health Science Center at Houston; Department of Basic Vision Sciences (J.S.B.), College of Optometry Texas Institute for Measurement Evaluation and Statistics, and Department of Psychology (J.H.), University of Houston; and Department of Neurosurgery (S.G., C.S.R.), Baylor College of Medicine, Houston, Texas.
Abstract
BACKGROUND: The incidence of adult respiratory distress syndrome (ARDS) in severe traumatic brain injury (TBI) is poorly reported. Recently, a new definition for ARDS was proposed, the Berlin definition. The percentage of patients represented by TBI in the Berlin criteria study is limited. This study describes the incidence and associated mortality of ARDS in TBI patients. METHODS: The study was an analysis of the safety of erythropoietin administration and transfusion threshold on the incidence of ARDS in severe TBI patients. Three reviewers independently assessed all patients enrolled in the study for acute lung injury/ARDS using the Berlin and the American-European Consensus Conference (AECC) definitions. A Cox proportional hazards model was used to assess the relationship between ARDS and mortality and 6-month Glasgow Outcome Scale (GOS) score. RESULTS:Two hundred patients were enrolled in the study. Of the patients, 21% (41 of 200) and 26% (52 of 200) developed ARDS using the AECC and Berlin definitions, respectively, with a median time of 3 days (interquartile range, 3) after injury. ARDS by either definition was associated with increased mortality (p = 0.04) but not with differences in functional outcome as measured by the GOS score at 6 months. Adjusted analysis using the Berlin criteria showed an increased mortality associated with ADS (p = 0.01). CONCLUSION: Severe TBI is associated with an incidence of ARDS ranging from 20% to 25%. The incidence is comparable between the Berlin and AECC definitions. ARDS is associated with increased mortality in severe TBI patients, but further studies are needed to validate these findings. LEVEL OF EVIDENCE: Epidemiologic study, level II.
RCT Entities:
BACKGROUND: The incidence of adult respiratory distress syndrome (ARDS) in severe traumatic brain injury (TBI) is poorly reported. Recently, a new definition for ARDS was proposed, the Berlin definition. The percentage of patients represented by TBI in the Berlin criteria study is limited. This study describes the incidence and associated mortality of ARDS in TBI patients. METHODS: The study was an analysis of the safety of erythropoietin administration and transfusion threshold on the incidence of ARDS in severe TBI patients. Three reviewers independently assessed all patients enrolled in the study for acute lung injury/ARDS using the Berlin and the American-European Consensus Conference (AECC) definitions. A Cox proportional hazards model was used to assess the relationship between ARDS and mortality and 6-month Glasgow Outcome Scale (GOS) score. RESULTS: Two hundred patients were enrolled in the study. Of the patients, 21% (41 of 200) and 26% (52 of 200) developed ARDS using the AECC and Berlin definitions, respectively, with a median time of 3 days (interquartile range, 3) after injury. ARDS by either definition was associated with increased mortality (p = 0.04) but not with differences in functional outcome as measured by the GOS score at 6 months. Adjusted analysis using the Berlin criteria showed an increased mortality associated with ADS (p = 0.01). CONCLUSION: Severe TBI is associated with an incidence of ARDS ranging from 20% to 25%. The incidence is comparable between the Berlin and AECC definitions. ARDS is associated with increased mortality in severe TBI patients, but further studies are needed to validate these findings. LEVEL OF EVIDENCE: Epidemiologic study, level II.
Authors: Julien Bordes; Guillaume Lacroix; Pierre Esnault; Philippe Goutorbe; Jean Cotte; Eric Dantzer; Eric Meaudre Journal: Burns Date: 2014-03-28 Impact factor: 2.744
Authors: Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler Journal: N Engl J Med Date: 2000-05-04 Impact factor: 91.245
Authors: Martin C Holland; Robert C Mackersie; Diane Morabito; Andre R Campbell; Valerie A Kivett; Rajiv Patel; Vanessa R Erickson; Jean-Francois Pittet Journal: J Trauma Date: 2003-07
Authors: Claudia S Robertson; H Julia Hannay; José-Miguel Yamal; Shankar Gopinath; J Clay Goodman; Barbara C Tilley; Athena Baldwin; Lucia Rivera Lara; Hector Saucedo-Crespo; Osama Ahmed; Santhosh Sadasivan; Luciano Ponce; Jovanny Cruz-Navarro; Hazem Shahin; Imoigele P Aisiku; Pratik Doshi; Alex Valadka; Leslie Neipert; Jace M Waguspack; M Laura Rubin; Julia S Benoit; Paul Swank Journal: JAMA Date: 2014-07-02 Impact factor: 56.272
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Fred Rincon; Sayantani Ghosh; Saugat Dey; Mitchell Maltenfort; Matthew Vibbert; Jacqueline Urtecho; William McBride; Michael Moussouttas; Rodney Bell; John K Ratliff; Jack Jallo Journal: Neurosurgery Date: 2012-10 Impact factor: 4.654
Authors: Marcel Winkelmann; Jan-Dierk Clausen; Pascal Graeff; Christian Schröter; Christian Zeckey; Sanjay Weber-Spickschen; Philipp Mommsen Journal: In Vivo Date: 2019 Sep-Oct Impact factor: 2.155
Authors: Myles D Boone; Sayuri P Jinadasa; Ariel Mueller; Shahzad Shaefi; Ekkehard M Kasper; Khalid A Hanafy; Brian P O'Gara; Daniel S Talmor Journal: Neurocrit Care Date: 2017-04 Impact factor: 3.210
Authors: Yunbo Ke; Julie L Proctor; Chenou Zhang; Juliana Medina; Catriona H T Miller; Junghyun Kim; Thomas E Grissom; Anna A Birukova; Gary M Fiskum; Konstantin G Birukov Journal: Physiol Rep Date: 2022-07
Authors: Vijay Krishnamoorthy; Nancy Temkin; Jason Barber; Brandon Foreman; Jordan Komisarow; Fred K Korley; Daniel T Laskowitz; Joseph P Mathew; Adrian Hernandez; John Sampson; Michael L James; Raquel Bartz; Karthik Raghunathan; Benjamin A Goldstein; Amy J Markowitz; Monica S Vavilala Journal: Crit Care Med Date: 2021-10-01 Impact factor: 9.296
Authors: Merry Huang; Aron Gedansky; Catherine E Hassett; Carrie Price; Tracey H Fan; R Scott Stephens; Paul Nyquist; Ken Uchino; Sung-Min Cho Journal: Neurocrit Care Date: 2021-07-23 Impact factor: 3.210